ArticleViruses2026
Post-Pandemic Genomic Diversity and Lineage Turnover of Influenza Viruses in Mexico During 2022-2023.
Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Seasonal influenza circulation was profoundly disrupted during the COVID-19 pandemic, resulting in an unprecedented global decline in viral activity and genetic diversity. As non-pharmaceutical interventions gradually relaxed, influenza viruses re-emerged in multiple regions in 2022; however, genomic data from Latin America remain limited, particularly for the first post-pandemic season. In this study, we analyzed the epidemiological, genomic, and evolutionary patterns of influenza A and B viruses circulating in Mexico between June 2018 and June 2023, with a specific focus on the first post-pandemic season (June 2022-June 2023). More than 90% of the influenza virus genomes available from Mexico for this post-pandemic period were generated in this study, while data from earlier seasons were used for contextualization. Following a near-complete absence of influenza circulation during 2020-2021, viral activity re-emerged in late 2021 and intensified during 2022-2023. Post-pandemic circulation in Mexico was dominated by influenza A(H3N2), with a lower contribution from A(H1N1)pdm09 and a delayed re-emergence of B/Victoria; B/Yamagata was not detected. Genomic analyses revealed rapid lineage turnover after the pandemic, characterized by the predominance of post-pandemic clades and reduced genetic diversity compared with pre-pandemic seasons. Phylogenetic analyses indicated multiple introductions and strong regional connectivity across North and South America.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.